Interestingly, liraglutide was also disclosed to ameliorate PAH by interfering with the Drp1/NOX- and Atg-5/Atg-7/Beclin-1/LC3β pathways, which are involved in autophagy [38]. Here, DNM1L is linked to pulmonary arterial hypertension.